報價延遲最少15分鐘:2024/11/10 12:58 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.238 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-14.43/--
|
|
企業價值
2.58M
|
| 資產負債 |
|
每股賬面淨值
0.74
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.88M
|
|
每股收益
0.32
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/11/10 12:58 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. |